Lessons learnt from the management of a case of Lassa fever and follow-up of nosocomial primary contacts in Nigeria during Ebola virus disease outbreak in West Africa

Tropical Medicine and International Health

Volumn 20, Issue 11, 2015, Pages 1424-1430

  Iroezindu, Michael O ^a   Unigwe, Uche S ^a   Okwara, Celestine C ^a   Ozoh, Gladys A ^a   Ndu, Anne C ^a   Ohanu, Martin E ^a   Nwoko, Ugochukwu O ^a   Okoroafor, Uwadiegwu W ^a   Ejimudo, Esinulo ^b   Tobin, Ekaete A ^c   Asogun, Danny A ^c  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b NIGERIA CENTRE FOR DISEASE CONTROL   (Nigeria)

^c Irrua Specialist Hospital   (Nigeria)

Author keywords

Ebola; Lassa fever; lessons; primary contact; surveillance

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIMALARIAL AGENT; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; HEMOGLOBIN; RIBAVIRIN;

DISEASE CONTROL; DISEASE SPREAD; DISEASE TRANSMISSION; HEALTH WORKER; HOSPITAL SECTOR; LABORATORY METHOD; MANAGEMENT PRACTICE; PRIMARY HEALTH CARE; SOCIAL PARTICIPATION; STUDY METHOD; SURVEILLANCE AND ENFORCEMENT; VIRAL DISEASE;

ABDOMINAL PAIN; ADULT; ANOREXIA; ANTIVIRAL THERAPY; ARTICLE; CLINICAL FEATURE; DIZZINESS; EBOLA HEMORRHAGIC FEVER; FATIGUE; FEMALE; FEVER; FOLLOW UP; HEADACHE; HEART PALPITATION; HEMATURIA; HIGH RISK PATIENT; HIGH RISK POPULATION; HOSPITAL INFECTION; HOSPITAL PERSONNEL; HUMAN; INFECTION CONTROL; INTERNATIONAL NORMALIZED RATIO; LASSA FEVER; LEUKOCYTOSIS; LOW RISK PATIENT; LYMPHOCYTOSIS; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MEDICAL STUDENT; NIGERIA; POST EXPOSURE PROPHYLAXIS; PROTEINURIA; RASH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEXUAL ABSTINENCE; SLEEP DISORDER; SOCIAL PSYCHOLOGY; THROMBOCYTOPENIA;

NIGERIA;

EBOLA VIRUS; LASSA VIRUS;

EID: 84973463421     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12565     Document Type: Article

References (23)

1. Frame JD, Baldwin JM, Gocke DJ, Troup JM. Lassa fever, a new virus disease of man from West Africa: clinical description and pathological findings. Am J Trop Med Hyg 1970: 19: 670–676.
2. Ogbu O, Ajuluchukwu E, Uneke CJ. Lassa fever in West Africa sub region: an overview. J Vector Borne Dis 2007: 44: 1–11.
3. VHFC. Viral haemorrhagic fevers consortium: Lassa fever, 2013. Available at: http://www.vhfc.org/lassa_fever (accessed November 3, 2013)
4. McCormick JB. Epidemiology and control of Lassa fever. Curr Top Microbiol Immunol 1987: 134: 69–78.
5. Tomori O, Fabiyi A, Sorungbe A, Smith A, McCormick JB. Viral hemorrhagic fever antibodies in Nigerian populations. Am J Trop Med Hyg 1988: 38: 407–410.
6. Fisher-Hoch SP, Tomori O, Nasidi A et al. Review of cases of nosocomial Lassa fever in Nigeria: the high price of poor medical practice. BMJ 1995: 311: 857–859.
7. Inegbenebor U, Okosun J, Inegbenebor J. Prevention of Lassa fever in Nigeria. Trans R Soc Trop Med Hyg 2010: 4: 51–54.
8. Omilabu SA, Badaru SO, Okokhere P et al. Lassa fever, Nigeria, 2003 and 2004. Emerg Infect Dis 2005: 11: 1642–1644.
9. Ehichioya DU, Hass M, Olschlager S et al. Lassa fever, Nigeria, 2005–2008. Emerg Infect Dis 2010: 16: 1040–1041.
10. Nigeria Center for Disease Control (NCDC). Weekly epidemiological report. WER – Nigeria 2012; 2(18). Available at: http://www.fmh.gov.ng/images/stories/documents/WeeklyEpidemiologyReport_FMOH_11th_May_2012.pdf (accessed November 14, 2014).
11. Johnson KM, Lange JV, Webb PA, Murphy FA. Isolation and partial characterisation of a new virus causing acute haemorrhagic fever in Zaire. Lancet 1977: 1: 569–571.
12. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011: 377: 849.
13. Gatherer D The 2014 Ebola virus disease outbreak in West Africa. J Gen Virol 2014: 95: 1619–1624.
14. Singh SK & Ruzek D (eds). Viral Hemorrhagic Fevers. CRC Press, Taylor & Francis Group: Boca Raton, 2013, 444. ISBN 9781439884294.
15. World Health Organization. “Ebola response roadmap situation report update”. October 29, 2014. Geneva, Switzerland.
16. McCormick JB, King IJ, Webb PA et al. Lassa fever: effective therapy with Ribavirin. N Eng J Med 1986: 314: 20–26.
17. Bausch DG, Hadi CM, Khan SH, Lertora JJ. Review of the literature and proposed guidelines for the use of oral ribavirin as postexposure prophylaxis for Lassa fever. Clin Infect Dis 2010: 51: 1435–1441.
18. Federal Ministry of Health. Screening suspected patients for Ebola Virus Disease (EVD) in healthcare facilities: Standard Operating Procedure. August 11, 2014. Abuja, Nigeria.
19. The National Population Commission. Population and Housing Census of the Federal Republic of Nigeria. Priority tables (Volume I). National Population Commission: Abuja, Nigeria, 2006.
20. Atkin S, Anaraki S, Gothard P et al. The first case of Lassa fever imported from Mali to the United Kingdom, February 2009. Euro Surveill 2009; 14, pii: 19145.
21. Asogun DA, Adomeh DI, Ehimuan J et al. Molecular diagnostics for Lassa fever at Irrua Specialist Teaching Hospital, Nigeria: lessons learnt from two years of laboratory operation. PLoS Negl Trop Dis 2012: 6: e1839.
22. Ajayi NA, Nwigwe CG, Azuogu BN et al. Containing a Lassa fever epidemic in a resource-limited setting: outbreak description and lessons learned from Abakaliki, Nigeria (January–March 2012). Int J Infect Dis 2013: 17: e1011–e1016.
23. Lamunu M, Lutwama JJ, Kamugisha J et al. Containing a haemorrhagic fever epidemic: the Ebola experience in Uganda (October 2000–January 2001). Int J Infect Dis 2004: 8: 27–37.